Targeting c-MYC G-Quadruplexes for Cancer Treatment with Small Molecules
Scientia Pharmaceutica · 22.01.2025 · 93 (1) · 6
DOI: 10.3390/scipharm93010006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientia Pharmaceutica, online erschienen am 22.01.2025. Verfasst von Prasanth Thumpati und 4 weiteren Autor:innen. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Pharmaceutical Education and Research, Kolkata.
Abstract (Originalsprache)
Novel therapies are required due to the rising cancer burden. Conventional chemotherapeutics tend to be particularly toxic, but there is a promising alternative for oncogenes, such as c-MYC. Often overexpressed in many cancer types, the potential c-MYC oncogene seems essential to the development of cancer. Targeting c-MYC protein directly was limited, but these DNA structures composed of guanine-rich sequences suppress c-MYC transcription. This review discusses recent advances in developing small compounds that selectively bind to and stabilize c-MYC G-quadruplexes (G4). These molecules have also shown promise for the inhibition of c-MYC signaling and inhibition of tumor growth, suggesting that G-quadruplex targeting could be a promising therapeutic for cancer.
Förderung
- National Institute of Pharmaceutical Education and Research, Kolkata
Zitieren
APA
Thumpati, P., Rai, S. N., Prajapati, C., Ramakrishna, K., & Singh, S. K. (2025). Targeting c-MYC G-Quadruplexes for Cancer Treatment with Small Molecules. Scientia Pharmaceutica, 93(1), 6. https://doi.org/10.3390/scipharm93010006
Vancouver
Thumpati P, Rai SN, Prajapati C, Ramakrishna K, Singh SK. Targeting c-MYC G-Quadruplexes for Cancer Treatment with Small Molecules. Scientia Pharmaceutica. 2025;93(1):6. doi:10.3390/scipharm93010006
BibTeX
@article{Thumpati2025,
author = {Thumpati, Prasanth and Rai, Sachchida Nand and Prajapati, Chandrabhan and Ramakrishna, Kakarla and Singh, Santosh Kumar},
title = {Targeting c-MYC G-Quadruplexes for Cancer Treatment with Small Molecules},
journal = {Scientia Pharmaceutica},
year = {2025},
volume = {93},
number = {1},
pages = {6},
doi = {10.3390/scipharm93010006}
}
EUVIMED